Regeneron Pharmaceuticals, Inc. REGN
788.04
(7.98)
(1.00%)
as of 25 Sep
- Market cap
- $81.3B
- P/E
- 18.8×
Follow REGN
Indexes
indicate stock being part of an index,
Growth Flags
show if company had growth for consecutive years
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Older periods | |
|---|---|---|---|---|---|
| 14.04% | 14.55% | 14.87% | 15.19% |
+8 more TTM periods Free account |
|
| 10.83% | 11.28% | 11.50% | 11.80% | ||
ROIC |
9.34% | 9.20% | 8.82% | 9.14% | |
Return on Tangible Assets |
23.56% | 24.08% | 24.00% | 24.67% | |
Average Days of Receivables |
154.26 | 140.21 | 146.10 | 145.69 | |
Free Cash Flow per Share |
34.78 | 36.45 | 36.00 | 37.46 | |
Free Cash Flow |
3,575.20 | 3,791.00 | 3,765.20 | 3,881.00 | |
Capital Expenditures |
(1,106.10) | (1,221.70) | (1,213.70) | (1,190.00) | |
Piotroski F-Score |
5.00 | 4.00 | 4.00 | 4.00 | |
| Other line items | |||||
Cash ROIC |
11.23% | 11.89% | 11.70% | 12.04% | |
Accounts Receivable Turnover |
2.55 | 2.64 | 2.40 | 2.42 | |
Accounts Payable Turnover |
2.50 | 2.66 | 2.43 | 2.97 | |
Inventory Turnover |
0.75 | 0.73 | 0.67 | 0.66 | |
Average Days of Payables |
179.90 | 162.59 | 163.15 | 158.49 | |
Days of Inventory on Hand |
478.62 | 491.29 | 556.14 | 570.67 | |
Tax Rate |
(0.16) | (0.14) | (0.14) | (0.11) | |
Research and Development Expense of Revenue |
40.40% | 40.66% | 40.79% | 39.56% | |
Selling, General and Administrative Expense of Revenue |
17.65% | 18.20% | 18.82% | 19.07% | |
Share Based Compensation of Revenue |
6.35% | 6.67% | 6.93% | 7.36% | |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF/Net income |
1.08 | 1.13 | 1.11 | 1.11 | |
Depreciation/Fixed assets |
0.10 | 0.10 | 0.11 | 0.11 | |
Capex/Depreciation |
(2.09) | (2.26) | (2.23) | (2.27) | |
Revenue per Share |
151.12 | 143.46 | 137.12 | 137.53 | |
Operating CF per Share |
45.54 | 48.20 | 47.60 | 48.95 | |
Capex per Share |
(10.76) | (11.75) | (11.60) | (11.49) | |
Capex to Sales |
0.07 | 0.08 | 0.08 | 0.08 | |
Net Profit Margin |
27.86% | 29.65% | 31.41% | 32.13% |
Columns are period end dates